Rothschild Capital Partners, LLC Atri Cure, Inc. Transaction History

Rothschild Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2016 Sep 06, 2018	SELL	N/A	-3,480 Reduced 1.43%	240,260 $3.8 Million
Q2 2016 Sep 06, 2018	SELL	N/A	-26,901 Reduced 9.94%	243,740 $3.44 Million
Q1 2016 Sep 06, 2018	SELL	N/A	-57,010 Reduced 17.4%	270,641 $4.56 Million
Q4 2015 Sep 06, 2018	BUY	N/A	91,150 Added 38.54%	327,651 $7.35 Million
Q2 2015 Sep 06, 2018	BUY	N/A	236,501	236,501 $5.83 Million

228

46.4M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.56B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Rothschild Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Rothschild Capital Partners, LLC with notifications on news.